Reading CABR? Track it free: the weekly brief, plus an alert if the thesis breaks. No credit card.
Track CABR free→
CARING BRANDS INC (CABR)
NASDAQHealth CareDrug Manufacturers - Specialty & GenericSnapshot 2026-07-06
Watch· this week
$1.36+0.74%
Close 2026-07-06 · 1-day change
Recent financial performance sits well below its industry cohort — worth keeping an eye on, though it has not freshly broken.
The bottom line
The thesis is that CABR's growth potential is uncertain due to weak recent performance. The company has not released earnings data, making it hard to assess its trajectory. It trades at a high risk level, which suggests that expectations may not be met. If CABR misses earnings again, it could face continued pressure. Peer multiples imply a price about 12% below where it trades; this read is provisional.
as of 2026-07-06
Quick facts
- Exchange
- NASDAQ
- Sector
- Health Care
- Industry
- Drug Manufacturers - Specialty & Generic
- Market cap
- $12.27M
- Employees
- 3
- IPO date
- 2025-03-20
- Next earnings
- 2026-08-11
Price
Daily closes. Earnings/event dots are placed inline.
Adjusted daily closes (split & dividend). Scroll over the chart to zoom; click a range to reset.
EarningsMaterial event
What's priced in
(what the market already expects)What it's worth (estimated)
A consensus fair price across 0 valuation methods, at three horizons. Current price $1.36. As of 2026-07-06. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Fair value· primary
—
Range — – —
vs price: —
Method agreement —
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
3-year
—consensus
Range — – —
vs price: —
Method agreement —
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
5-year
—consensus
Range — – —
vs price: —
Method agreement —
A long-thesis check that carries the widest uncertainty of the three horizons.
How this stock is priced
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Long-term · 1–3 yr
12-month view
Not enough valuation methods to set a 12-month read yet.
Compared to peers
Not enough peers to compare yet.
Compared to its own history
Self-history needs ~20 months of data.
P/E
—
EV/EBITDA
—
FCF yield
-10.9%
Earnings yield (TTM)
Long-term · 1–3 yrHow strong is the business
(quality & execution)Factor signals
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Recent financial performance
Not enough signal yet.
Earnings quality
Not enough signal yet.
Macro sensitivity
Not enough signal yet.
Not enough signal to read sensitivity to the US dollar, the broad stock market, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity.
Management & capital allocation
neutral7 material management or governance events in the past 24 months, led by M&A activity. Historically, Health Care names rated neutral grew net income 50% of the time over the next year (vs 48% for the rest of the cohort, n=4965).
45th pctl · Health Care
Not investment advice. As of 2026-07-06.
Earnings setup & market context
The next print and the backdrop around it (sector regime and the AI cycle). Context for the path, not a forecast of returns.
Sector context
Intermediate · WeeklySector phase: health care is in maturing, with decelerating (~0.5 years in phase).
Sector regime (90d momentum): headwind.Secular epoch: Mature by revenue growth · theme AI-drug-discovery.headwind-2.7%sector vs S&P 500, 60d
via XLV
Tailwind = sector leading the S&P 500; headwind = trailing. Both can be constructive. Historically, headwind regimes have averaged stronger forward returns than tailwind.
AI cycle regime · market-wide
2-axis classifierLong-term · 1–3 yr
Management scorecard
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
Long-term · 1–3 yr
Provisional
- Post-call reaction
- weak
A guidance track record builds as the company issues and delivers on guidance.
as of 2026-07-06
What management is focused on
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Long-term · 1–3 yr
- #1
How bumpy is the path
(risk while you hold it)Risk: how this stock moves
What a normal day, a bad day, and the worst of the last year would mean for a $10,000 position.
Intermediate · WeeklyLong-term · 1–3 yr
On a typical day, $10k can swing ±$437.
How much price usually moves either way.
On a bad day, this stock has moved -$1,154.
A rough but not unusual down day (about the 95th percentile).
In the worst 12 months, $10k could have lost $8,380.
Deepest peak-to-trough drop in the last year.
highas of 2026-07-06
Past results, not a forecast. Not investment advice.
What would change the read
(catalysts & re-read triggers)What changed
The most important moves since the prior daily snapshot.
Short-term · Daily
- risk change · risk_labelsmall change
risk label changed from 'elevated' to 'high'.
No, our read on the company is unchanged. There are no new strengths or weaknesses identified that would alter the current assessment. The risk label has changed from "elevated" to "high," indicating increased caution, but this does not shift the overall read on CABR.
as of 2026-07-06
What to watch next
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Intermediate · Weekly
- DownsideHigh confidenceMonthsactive 17d
Watch for Nasdaq compliance updates
Why it matters: Caring Brands needs to meet Nasdaq rules to avoid delisting. Compliance is crucial for investor confidence.
What confirms / what disproves
Confirms:Caring Brands says it has at least $2.5 million in stockholders' equity.
Disproves:Caring Brands fails to meet the Nasdaq compliance requirements again.
Material event
News catalysts
Recent news graded against this company's own objectives — whether it reinforces or challenges the thesis, and how confirmed it is.
No graded news catalysts for CABR yet.
This sector is also watching
- Watch for Health Care revenue growth to re-accelerate above 10%
What could change this view
Conditional scenarios: if X happens, the view would shift in this direction. These are not predictions.
Intermediate · Weekly
Upside triggers
- If sector bellwethers like HLN, TEVA, and ZTS keep beating earnings and guiding higher, the Healthcare sector momentum should keep lifting CABR and other Healthcare names. Worth watching these names for early signals.
- If the Fed starts cutting rates from the current 3.63%, that would be a tailwind for CABR and other Healthcare names, since rate-sensitive parts of the market tend to rally when the Fed eases.
Downside triggers
- If sector bellwethers like HLN, TEVA, and ZTS start missing or guiding lower, the Healthcare tailwind helping CABR and other Healthcare names could fade. Watch these names for early warning.
- If CABR misses again next quarter like this past one (a big miss of -80% on the 2025-09-30 print), expect continued pressure. The Street usually keeps walking estimates down after consecutive misses.
- If GDP growth slows materially from the current 2.7% (say, below 2%), it hits CABR and other Healthcare names harder than the average stock, since the sector is growth-sensitive.
Recent events
(material 8-K / filing activity)Material updates
Recent SEC 8-K filings ranked by likely impact, confidence, and recency.
- 2026-04-102mo agoItem 3.01
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On April 7, 2026, Caring Brands, Inc. (the “ Company ”) received a Staff Delisting Determination letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires the Company to maintain a minimum of $2.5 million in stockholders’ equity for contin…
Legal / regulatorynegative
Score history
Whether the overall read has been drifting up or down lately, and how it's changed since last week.
No score history yet for this stock.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.